Helius Medical Technologies to Present at Upcoming Healthcare Investor Conferences in September
NEWTOWN, Pa., Sept. 06, 2022 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that Dane Andreeff, President and Chief Executive Officer, and Jeff Mathiesen, Chief Financial Officer, will present at two upcoming healthcare conferences as follows:
Related news for (HSDT)
- Dealmaking Drives the Tape: These Stocks Are Heating Up into the Close
- Capital Meets Conviction: VENU, HSDT, GLUE, and IHT Show Investors the Money
- MoBot alert highlights: NASDAQ: HSDT, NASDAQ: RCEL, NYSE: GPUS, NYSE: ATCH, NASDAQ: HYFT (09/15/25 06:00 AM)
- MoBot alert highlights: NYSE: ATCH, NASDAQ: HSDT, NASDAQ: HYFT, NASDAQ: HAIN, NASDAQ: BTBD (09/15/25 05:00 AM)
- Today’s Top Performers: MoBot’s Market Review 09/15/25 04:00 AM